Oricell Therapeutics Secures $110 Million in Pre-IPO Funding to Accelerate Groundbreaking Solid Tumor Cell Therapy Development
Shanghai-based Oricell Therapeutics, a burgeoning force in the biotechnology sector, has successfully closed a pre-initial...
